NF-IL6 (C/EBPbeta ) vigorously activates il1b gene expression via a Spi-1 (PU.1) protein-protein tether.
about
IL-32θ negatively regulates IL-1β production through its interaction with PKCδ and the inhibition of PU.1 phosphorylationSelective suppression of CCAAT/enhancer-binding protein beta binding and cyclooxygenase-2 promoter activity by sodium salicylate in quiescent human fibroblastsHeat shock factor 1 represses transcription of the IL-1beta gene through physical interaction with the nuclear factor of interleukin 6Toll-like receptor 2 and 4 (TLR2 and TLR4) agonists differentially regulate secretory interleukin-1 receptor antagonist gene expression in macrophages.Ets-2 and C/EBP-beta are important mediators of ovine trophoblast Kunitz domain protein-1 gene expression in trophoblast.Monocytes from cystic fibrosis patients are locked in an LPS tolerance state: down-regulation of TREM-1 as putative underlying mechanism.Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage.Regulation of Ets function by protein - protein interactions.Ets target genes: past, present and future.When Ets transcription factors meet their partners.Signal transduction and the Ets family of transcription factors.Distinct mechanisms for induction and tolerance regulate the immediate early genes encoding interleukin 1β and tumor necrosis factor α.Activation of interleukin 1beta gene transcription by human cytomegalovirus: molecular mechanisms and relevance to periodontitis.Cytokine gene polymorphism and immunoregulation in periodontal disease.Inhibition of IL-1beta transcription by peptides derived from the hCMV IE2 transactivator.M-CSF increases proliferation and phagocytosis while modulating receptor and transcription factor expression in adult human microglia.Phosphorylation of IRF8 in a pre-associated complex with Spi-1/PU.1 and non-phosphorylated Stat1 is critical for LPS induction of the IL1B geneTSC1 controls IL-1β expression in macrophages via mTORC1-dependent C/EBPβ pathway.Cooperation between PU.1 and CAAT/enhancer-binding protein beta is necessary to induce the expression of the MD-2 gene.PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis.Recent advances in the structural molecular biology of Ets transcription factors: interactions, interfaces and inhibition.YY1 is a positive regulator of transcription of the Col1a1 gene.Molecular characterization of a cancer-related single nucleotide polymorphism in the pro-inflammatory interleukin-1B gene.Eicosapentaenoic acid demethylates a single CpG that mediates expression of tumor suppressor CCAAT/enhancer-binding protein delta in U937 leukemia cellsMyeloid-derived NF-κB negative regulation of PU.1 and c/EBP-β-driven pro-inflammatory cytokine production restrains LPS-induced shock.CCAAT/enhancer-binding protein beta inhibits proliferation in monocytic cells by affecting the retinoblastoma protein/E2F/cyclin E pathway but is not directly required for macrophage morphology.HSF1 regulates expression of G-CSF through the binding element for NF-IL6/CCAAT enhancer binding protein beta.Interleukin-3 stimulation of mcl-1 gene transcription involves activation of the PU.1 transcription factor through a p38 mitogen-activated protein kinase-dependent pathway.Dynamic protein associations define two phases of IL-1beta transcriptional activation.Characterization of the survival motor neuron (SMN) promoter provides evidence for complex combinatorial regulation in undifferentiated and differentiated P19 cellsThe possible functions of duplicated ets (GGAA) motifs located near transcription start sites of various human genesAmino acid residues in the beta3 strand and subsequent loop of the conserved ETS domain that mediate basic leucine zipper (bZIP) recruitment and potentially distinguish functional attributes of Ets proteins.Heat shock factor 1 contains two functional domains that mediate transcriptional repression of the c-fos and c-fms genes.Conserved ETS domain arginines mediate DNA binding, nuclear localization, and a novel mode of bZIP interaction.Polymorphism in IL1B: IL1B-511 association with tuberculosis and decreased lipopolysaccharide-induced IL-1beta in IFN-gamma primed ex-vivo whole blood assay.Elevated levels of IL-1beta in Fanconi anaemia group A patients due to a constitutively active phosphoinositide 3-kinase-Akt pathway are capable of promoting tumour cell proliferation.IL-32θ: a recently identified anti-inflammatory variant of IL-32 and its preventive role in various disorders and tumor suppressor activity.Microphthalmia transcription factor and PU.1 synergistically induce the leukocyte receptor osteoclast-associated receptor gene expression.Upregulation of interleukin-1β production by 1,25-dihydroxyvitamin D(3) in activated human macrophages.
P2860
Q24300286-7D547B4E-FFC1-4983-B122-7AB741181317Q28181159-A84B9F85-7B9B-41C0-81A7-C67E0C6F63FBQ28215984-7423C198-E5F0-4DCF-B60F-D549F6A06A42Q30308835-8C8D42C7-940A-44E6-80DE-DB87E9516DB8Q33275849-E25BEB78-F739-4B31-856D-F1CEF583D1B5Q33352036-7D31FBFF-8873-4D7B-8D05-0207B2FB9639Q33587139-E104A7E7-65CD-49EE-8220-EF70C7088434Q33933221-FBA5E571-942E-4614-9E66-0BDC01069DB3Q33933227-D889E93A-5C35-4D80-9729-C23E6AF6402CQ34123332-258ABD65-6405-4635-8FB7-30274131E4E4Q34139409-5FD72883-908B-4B6F-B7AE-5FC33A7FB905Q34926054-6B94B674-01F7-4B19-A186-DCA769BC29F0Q35091083-37AABE60-A22C-49AB-910C-91EEBCBBDE3BQ35755302-91F89D69-D5A9-450B-8728-796CBDCA7B53Q36620691-3788EC84-A7E9-4CB0-BCE4-7E3679A54858Q37060394-A66A9859-A6E1-4C42-AD73-EF83E18B2234Q37284465-5F3C3ECF-B88E-43BE-A3A4-D4AA4DD4DFBEQ37284999-AD335654-7819-4AF8-BB01-9C25CF91A70DQ37446624-D32636C2-867A-4BF9-A92F-5CF774C50C0EQ37453513-60448678-8879-44F3-9779-E3BC639C9A04Q38180770-C7F7B286-8129-4FCE-A1E0-29BBE6A006E2Q38297636-45AF3BDC-B5B4-4EF6-A652-630D53F52082Q38326476-271CB39A-080A-4D6D-B724-78FCA7D5688DQ38334440-71FE6C15-97FC-440A-86B0-CDEEBCACF3F5Q39117977-5F780FC9-BC1B-4E55-A89F-0D5C8109FE6DQ39545169-39DD6AFF-8355-4F12-B425-92D281C8CF26Q39566669-408A282C-44D5-4033-8345-F2B366EB1456Q39732380-DF4EDA17-FD8D-46A0-8945-7816A76D943CQ39970299-5C6CD7CF-9062-4536-9799-ADF55D2D5110Q40516758-64D7B469-A87D-4A7D-8DEF-BB8FBD361950Q42738749-942D1E98-6A84-4CCE-B178-D61BF86BE9DFQ43045210-99FE7A95-5EC8-415E-9573-FE99CF1C1253Q44240358-A9D88748-AD9E-4928-96A2-B195B2B1FC9FQ46751768-8F22A05D-1338-4D8D-825B-A68B02F0366DQ46989917-B45DADA5-3EAC-48B3-93F8-D77DC844A685Q47717772-716D3297-4D5C-4F65-A06F-1B8544E63B1BQ49320015-5C5A24C2-2115-4422-AF20-5EAFFAE28E0EQ53656611-CB907DAB-8A62-4E3A-BFB4-D1E8CA18BEBDQ54649429-B72259F0-4E4C-4302-8407-8A792185B4AB
P2860
NF-IL6 (C/EBPbeta ) vigorously activates il1b gene expression via a Spi-1 (PU.1) protein-protein tether.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
NF-IL6 (C/EBPbeta ) vigorously ...... (PU.1) protein-protein tether.
@en
NF-IL6
@nl
type
label
NF-IL6 (C/EBPbeta ) vigorously ...... (PU.1) protein-protein tether.
@en
NF-IL6
@nl
prefLabel
NF-IL6 (C/EBPbeta ) vigorously ...... (PU.1) protein-protein tether.
@en
NF-IL6
@nl
P2093
P2860
P356
P1476
NF-IL6 (C/EBPbeta ) vigorously ...... (PU.1) protein-protein tether.
@en
P2093
P2860
P304
21272-21277
P356
10.1074/JBC.M000145200
P407
P577
2000-07-01T00:00:00Z